Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
InxMed Announces First Patient Dosed in Phase 2 Pivotal Study of IN10018 In Patients with Platinum-Resistant Recurrent Ovarian Cancer 2022-09-08 08:00
Biosion, Inc. Appoints Dr. Rakesh Dixit, ADC Thought Leader, to Advisory Board 2022-09-07 20:54
Lianhua Products Designated as Epidemic Prevention Supplies : 2022 CIFTIS 2022-09-07 20:15
Tycoon Group Signs Cooperation Agreement with JD Logistics, Obtains Operating Rights of Logistics Supply Chain Industry Bases in France 2022-09-07 20:13
GenFleet Therapeutics to Present Data from Phase I Trial of GFH018 Monotherapy at the 2022 European Society for Medical Oncology Annual Meeting 2022-09-07 19:00
Waterdrop Announces Appointment of a New Director 2022-09-07 16:54
Laekna Announces First Patient Dosed in South Korea in LAE201INT2101 Phase 1/2 Study 2022-09-06 17:02
Amcor reveals Lift-Off seed capital winners with investments that seek to "drive the revolution in packaging" 2022-09-06 16:10
Jacobio Receives CDE Approval for KRAS G12C Inhibitor JAB-218822's Phase II Pivotal Study in China 2022-09-06 15:20
Dizal Announces Sunvozertinib Meets Primary Endpoint in its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMO 2022-09-05 22:49
Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMO 2022-09-05 22:39
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US 2022-09-05 21:09
Lunit to Showcase 5 Abstracts at ESMO 2022 2022-09-05 21:00
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives 2022-09-05 16:00
Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue 2022-09-05 13:09
Tamas Oravecz Ph.D. named SVP, CSO of the U.S. of Simcere Pharmaceutical Group 2022-09-05 13:08
New Building Stands as Symbol of Dignity and Hope For Persons Affected by Leprosy in Ethiopia 2022-09-02 22:00
Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products 2022-09-02 20:50
Waterdrop Inc. to Report Second Quarter 2022 Financial Results on September 9, 2022 2022-09-02 20:00
Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China 2022-09-02 19:00
1 139 140 141 142 143 811